Trademark

Trademark Overview


On Tuesday, June 11, 2024, a trademark application was filed for with the United States Patent and Trademark Office. The USPTO has given the trademark a serial number of 98595799. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Wednesday, April 2, 2025. This trademark is owned by Flatiron Health, Inc.. The trademark is filed in the Advertising, Business and Retail Services category with the following description:

Providing technological, scientific, and business information for the purpose of advancing understanding of innovation and research in the field of oncology and improving the quality of cancer care
</cancer>

General Information


Serial Number98595799
Word Mark
Filing DateTuesday, June 11, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateWednesday, April 2, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesProviding technological, scientific, and business information for the purpose of advancing understanding of innovation and research in the field of oncology and improving the quality of cancer care

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateTuesday, June 11, 2024
Primary Code035
First Use Anywhere DateSunday, March 31, 2024
First Use In Commerce DateSunday, March 31, 2024

Trademark Owner History


Party NameFlatiron Health, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10013

Trademark Events


Event DateEvent Description
Tuesday, June 11, 2024NEW APPLICATION ENTERED
Sunday, December 29, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, December 30, 2024NON-FINAL ACTION E-MAILED
Monday, December 30, 2024ASSIGNED TO EXAMINER
Monday, March 31, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 31, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 31, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 2, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, April 2, 2025NON-FINAL ACTION WRITTEN
Wednesday, April 2, 2025NON-FINAL ACTION E-MAILED
Monday, December 30, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 30, 2024NON-FINAL ACTION WRITTEN